Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands		3 Months Ended		6 Months Ended		12 Months Ended
		Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Operating activities
Net loss		$ (42,843)	$ (552,212)	$ (110,880)	$ (616,955)
Adjustments to reconcile net loss to net cash used in operating activities
Change in fair value of warrant liability				0	(900)
Stock-based compensation				45,429	488,313
Gain on warrant exercise				0	(173)
Gain on marketable equity securities		(37,812)	3,705	(6,007)	(2,541)
Deferred income taxes				(46,216)	0
Loss from equity-method investments		2,100	0	3,983	0
Amortization of original issue discount				1,169	691
Amortization of deferred financing fees				332	255
Change in fair value of contingent consideration				0	165
Change in fair value of holdback liability				312	0
Amortization of warrant contract asset				0	2,422
Depreciation and amortization				48,385	18,348
Provision for bad debt expense				625	327
Change in fair value of warrant asset				0	7,700
Non-cash operating lease costs				4,573	3,252
Minimum accretion expense				108	92
PIK interest added to principal				7,157	4,366
Change in assets and liabilities
Accounts receivable				(49,155)	(23,971)
Inventory				1,974	(3,845)
Prepaid expenses and other current assets				(188)	(12,409)
Investments and other assets				(11,073)	1,294
Accounts payable				7,025	(33,371)
Deferred revenue	[1]			36,836	(28,669)
Deferred other income				(7,977)	0
Accrued data licensing fees				3,957	(2,749)
Accrued expenses & other				6,991	(2,805)
Interest payable				7,122	7,287
Operating lease liabilities				(5,942)	(4,582)
Net cash used in operating activities				(61,460)	(198,458)
Investing activities
Purchases of property and equipment				(9,588)	(14,116)
Proceeds from sale of marketable equity securities				8,316	23,098
Business combinations, net of cash acquired				(380,762)	0
Purchases of capitalized software				(3,295)	0
Net cash (used in) provided by investing activities				(385,329)	8,982
Financing activities
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions				0	381,951
Tax withholding related to net share settlement of restricted stock units				0	(69,918)
Issuance of Series G-5 Preferred Stock				0	199,750
Payment of deferred offering costs				0	(2,714)
Dividends paid				0	(5,625)
Proceeds from revolving credit facility, net of original issue discount				98,000	0
Proceeds from long-term debt, net of original issue discount				196,000	0
Payment of deferred financing fees				(958)	0
Payment of indemnity holdback related to acquisition				0	(813)
Net cash provided by financing activities				293,042	502,631
Effect of foreign exchange rates on cash				(37)	(90)
Net (decrease) increase in Cash, Cash Equivalents and Restricted Cash				(153,784)	313,065
Cash, cash equivalents and restricted cash, beginning of period				341,835	166,607	$ 166,607
Cash, cash equivalents and restricted cash, end of period		188,051	479,672	188,051	479,672	341,835
Cash, Cash Equivalents and Restricted Cash are Comprised of:
Cash and cash equivalents		186,310	478,811	186,310	478,811	340,954
Restricted cash and cash equivalents		1,741	861	1,741	861
Total cash, cash equivalents and restricted cash		$ 188,051	$ 479,672	188,051	479,672	$ 341,835
Supplemental disclosure of cash flow information
Cash paid during the year for interest				23,980	13,921
Cash paid for income taxes				136	89
Supplemental disclosure of noncash investing and financing activities
Dividends Payable				0	5,487
Purchases of property and equipment, accrued but not paid				6,863	1,108
Redemption of convertible promissory note				14,338	12,476
Non-voting common stock issued in connection with business combinations				0	344
Deferred financing fees, accrued but not yet paid				545	0
Deferred offering costs, accrued but not yet paid				95	6,051
Operating lease liabilities arising from obtaining right-of-use assets				606	0
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering				0	1,348,809
Taxes related to net share settlement of restricted stock units not yet paid				0	164
Reclassification of deferred offering costs to additional paid-in capital upon initial public offering				0	12,347
Class A Voting Common Stock issued in connection with business combinations				310,320	0
Convertible promissory note principal reset due to amendment				72,488	0
Series G-3 Redeemable Convertible Preferred Stock [Member]
Supplemental disclosure of noncash investing and financing activities
Issuance of Series				0	3,809
Series G-4 Redeemable Convertible Preferred Stock [Member]
Supplemental disclosure of noncash investing and financing activities
Issuance of Series				$ 0	$ 611

[1] Includes increase in related party deferred revenue of $36,685 and $0 as of June 30, 2025 and December 31, 2024, respectively.